Extensive colonic resection or subtotal or total colectomy

Currently required or anticipated surgical intervention during the study

Any prior exposure to natalizumab, efalizumab, or rituximab

History or evidence of colonic mucosal dysplasia

Female patients who are lactating or have a positive pregnancy test

Any unstable or uncontrolled medical disorder that, in the opinion of the investigator, would confound the study results or compromise patient safety.

The Safety and Efficacy of Good Feeling Power® for IBD Patients

What this study is about